DBV Technologies | Eiendeler



Assets Endring Dato
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amarin USD 750.62M 49.24M 2024-09
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
DBV Technologies USD 65.7M 27.36M 2024-12
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Incyte USD 5.75B 305.04M 2025-03
Insmed USD 2.03B 27.74M 2024-12
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Ultragenyx Pharmaceutical USD 1.5B 34.91M 2024-12
United Therapeutics USD 7.74B 379.9M 2025-03



DBV Technologies Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.